1-3 of 3
Meera Patturajan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 2a Study Evaluating the Safety and Pharmacokinetics (PK) of Luspatercept in Pediatric Patients with Transfusion-Dependent β-Thalassemia (TDT)

Vip Viprakasit, Thomas D. Coates, Khaled M. Musallam, Julie Vienne Buerki, Meera Patturajan, Natalia Holot, Yesim Aydinok
Journal: Blood
Blood (2021) 138 (Supplement 1): 4161.
https://doi.org/10.1182/blood-2021-145698
Published: 2021
Journal Articles

Efficacy, Safety, and Pharmacokinetics (PK) of Azacitidine (AZA) in Children and Young Adults with Acute Myeloid Leukemia (AML) in the Phase 2 AZA-AML-004 Trial

Dirk Reinhardt, MD, Henrik Hasle, PhD, Karsten Nysom, André Baruchel, Franco Locatelli, MD PhD, Bouchra Benettaib, Noha Biserna, Meera Patturajan, Mathew Simcock, Allison Gaudy, C. Michel Zwaan
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–11.
https://doi.org/10.1182/blood-2020-137043
Published: 2020
Journal Articles

Phase II Randomized, Multicenter Study of Lenalidomide Vs Best Investigator’s Choice in Relapsed/Refractory Mantle Cell Lymphoma: Results of the MCL-002 (SPRINT) Study

Marek Trneny, Thierry Lamy, Jan Walewski, Wojciech Jurczak, David Belada, MD, Jiri Mayer, Prof., MD PhD, John Radford, Julia Alexeeva, Dzhelil Osmanov, Tsvetan Biyukov, Meera Patturajan, Marie-Laure Casadebaig Bravo, Luca Arcaini
Journal: Blood
Blood (2014) 124 (21): 626.
https://doi.org/10.1182/blood.V124.21.626.626
Published: 2014